The Collier Report of U.S. Government Contracting

Old School Reporting Using Modern Technology

Dynport Vaccine Company Llc

  • Contact Person: Helaine (lannie) Elderkin
  • Contact Phone: 703-641-2532
  • Contact Email: LANNIE.ELDERKIN@CSRA.COM
  • Business Structure:
  • Corporate Entity (Not Tax Exempt)
  • Business Type:
  • For Profit Organization
  • Limited Liability f
  • Industries Served: Medicinal and Botanical Manufacturing, Pharmaceutical Preparation Manufacturing, Biological Product (except Diagnostic) Manufacturing, Engineering Services, Custom Computer Programming Services, Computer Systems Design Services, Other Computer Related Services, Administrative Management and General Management Consulting Services, Marketing Consulting Services, Process, Physical Distribution, and Logistics Consulting Services, Other Management Consulting Services, Other Scientific and Technical Consulting Services
  • Product Areas: TRANSPORTATION/TRAVEL/RELOCATION- TRAVEL/LODGING/RECRUITMENT: AMBULANCE, AMBULANCE SERVICE

Sampling of Federal Government Funding Actions/Set Asides

In order by amount of set aside monies.

  • $97,254 - Thursday the 16th of August 2012
    National Institutes Of Health
    NIH, NIAID DEA OA OFC ACQUISITIONS
    PHASE 1 CLINICAL TRIAL UNIT FOR THERAPEUTICS AGAINST INFECTIOUS DISEASES
  • $911,049 - Tuesday the 10th of June 2014
    Department Of Army
    W6QK ACC-APG NATICK
    P00359
  • $6,269,105 - Tuesday the 10th of June 2014
    Department Of Army
    W6QK ACC-APG NATICK
    P00360
  • $520,000 - Tuesday the 22nd of May 2012
    National Institutes Of Health
    NIH, NIAID DEA OA OFC ACQUISITIONS
    PHASE 1 CLINICAL TRIAL UNIT FOR THERAPEUTICS AGAINST INFECTIOUS DISEASES
  • $440,000 - Friday the 2nd of December 2011
    National Institutes Of Health
    NIH, NIAID DEA OA OFC ACQUISITIONS
    PHASE 1 CLINICAL TRIAL UNIT FOR THERAPEUTICS AGAINST INFECTIOUS DISEASES
  • $3,622,483 - Wednesday the 27th of June 2012
    National Institutes Of Health
    NIH, NIAID DEA OA OFC ACQUISITIONS
    PHASE 1 CLINICAL TRIAL UNIT FOR THERAPEUTICS AGAINST INFECTIOUS DISEASES
  • $35,438,081 - Tuesday the 10th of June 2014
    Department Of Army
    W6QK ACC-APG NATICK
    SLIN 0001AA
  • $3,000,000 - Tuesday the 10th of June 2014
    Department Of Army
    W6QK ACC-APG NATICK
    P00369
  • $24,757,000 - Tuesday the 10th of June 2014
    Department Of Army
    W6QK ACC-APG NATICK
    SLIN 0001AA
  • $1,716,568 - Tuesday the 10th of June 2014
    Department Of Army
    W6QK ACC-APG NATICK
    MOD

© Copyright 2019
The Collier Report
published by 1918 Media LLC.
Information displayed in this dossier has been provided through available open source or public sources. No reliance should be made by readers or Collier Report subscribers. Funding actions are complicated and do not always represent dollar-for-dollar payments to vendors nor do they represent payments in certain instances. Requests for the modification of displayed information may be made to help.desk@1918.media.